
1 Stock to Buy This Week Following Its Recent Earnings Beat
Published on November 7, 2022
Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should...
